Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use

被引:0
|
作者
James E. Frampton
机构
[1] Springer Nature,
来源
CNS Drugs | 2021年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A correction to this paper has been published: https://doi.org/10.1007/s40263-021-00828-7
引用
收藏
页码:701 / 701
相关论文
共 50 条
  • [31] OnabotulinumtoxinA Injections for Chronic Migraine Prophylaxis
    Carter, Eric
    Kwon, Edward
    AMERICAN FAMILY PHYSICIAN, 2019, 100 (04) : 198 - 198
  • [32] Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine
    Durham, Paul L.
    Cady, Roger
    HEADACHE, 2011, 51 (10): : 1573 - 1577
  • [33] Response to "OnabotulinumtoxinA for the treatment of chronic migraine not quite there ..."
    Aurora, Sheena
    CEPHALALGIA, 2011, 31 (03) : 378 - 379
  • [34] OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
    Zandieh, Ali
    Cutrer, Fred Michael
    BMC NEUROLOGY, 2022, 22 (01)
  • [35] Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy
    Smirnoff, Liza
    FRONTIERS IN PAIN RESEARCH, 2022, 3
  • [36] OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
    Ali Zandieh
    Fred Michael Cutrer
    BMC Neurology, 22
  • [37] Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
    Russell, Michael Bjorn
    JOURNAL OF HEADACHE AND PAIN, 2011, 12 (02): : 135 - 136
  • [38] Chronic migraine treatment: from OnabotulinumtoxinA onwards
    Negro, Andrea
    Curto, Martina
    Lionetto, Luana
    Giamberardino, Maria Adele
    Martelletti, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1217 - 1227
  • [39] OnabotulinumtoxinA for Treatment of Chronic Migraine: The Unblinding Problem
    Solomon, Seymour
    HEADACHE, 2013, 53 (05): : 824 - 826
  • [40] Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
    Michael Bjørn Russell
    The Journal of Headache and Pain, 2011, 12 : 135 - 136